Gufic Biosciences Limited (BOM:509079)

Gufic Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	762.17	157.23	11.37	286.02	116.08
Cash & Short-Term Investments	762.17	157.23	11.37	286.02	116.08
Cash Growth	384.74%	1283.12%	-96.03%	146.40%	87.18%
Accounts Receivable	2,974	3,146	3,299	2,055	1,516
Other Receivables	15.71	15.71	-	-	-
Receivables	2,996	3,165	3,303	2,057	1,519
Inventory	3,245	2,169	2,005	1,835	1,156
Prepaid Expenses	-	13.11	8.61	9.5	8.51
Other Current Assets	1,018	741.2	676.9	454.29	407.93
Total Current Assets	8,021	6,245	6,005	4,641	3,208
Property, Plant & Equipment	5,070	5,215	4,603	3,285	1,554
Long-Term Investments	17.84	17.84	17.84	7.84	0.08
Other Intangible Assets	61.64	63.44	56.19	6.79	6.1
Long-Term Deferred Tax Assets	-	-	-	9.66	-
Other Long-Term Assets	247.91	150.33	239.13	658.02	443.58
Total Assets	13,424	11,694	10,925	8,612	5,214

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1,990	1,587	1,663	1,303	1,410
Accrued Expenses	-	197.36	184.07	143.78	172.45
Short-Term Debt	-	1,543	1,420	1,118	65.99
Current Portion of Long-Term Debt	2,801	256.08	210.54	89.67	66.65
Current Portion of Leases	52.18	62.27	43.26	65.76	28.17
Current Income Taxes Payable	18.61	-	25.45	31.24	6.75
Other Current Liabilities	316.15	229.7	174.31	131.37	114.5
Total Current Liabilities	5,178	3,876	3,720	2,882	1,864
Long-Term Debt	1,050	1,305	1,540	1,907	479.78
Long-Term Leases	143.73	195.93	115.55	162.1	3.29
Pension & Post-Retirement Benefits	-	105.32	90.59	77.75	65.88
Long-Term Deferred Tax Liabilities	165.74	77.72	20.63	-	1.9
Other Long-Term Liabilities	235.56	123.34	112.92	104.8	107.98
Total Liabilities	6,774	5,683	5,600	5,134	2,523

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	100.28	100.28	100.28	96.95	96.95
Additional Paid-In Capital	-	996.57	996.57	-	-
Retained Earnings	-	4,223	3,538	2,686	1,899
Comprehensive Income & Other	6,549	690.49	690.72	694.76	695.22
Total Common Equity	6,649	6,011	5,326	3,478	2,691
Minority Interest	0.38	-	-	-	-
Shareholders' Equity	6,650	6,011	5,326	3,478	2,691
Total Liabilities & Equity	13,424	11,694	10,925	8,612	5,214

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	4,048	3,362	3,329	3,342	643.87
Net Cash (Debt)	-3,285	-3,205	-3,318	-3,056	-527.79
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-32.74	-31.96	-33.68	-31.52	-5.44
Filing Date Shares Outstanding	100.44	100.28	100.28	96.94	96.94
Total Common Shares Outstanding	100.44	100.28	100.28	96.94	96.94
Working Capital	2,843	2,370	2,284	1,759	1,344
Book Value Per Share	66.20	59.94	53.11	35.88	27.76
Tangible Book Value	6,588	5,947	5,269	3,471	2,685
Tangible Book Value Per Share	65.59	59.31	52.55	35.81	27.70
Land	-	103.9	98.9	-	-
Buildings	-	1,230	383.55	417.59	355.81
Machinery	-	4,167	1,516	1,534	1,229
Construction In Progress	-	218.16	3,071	1,696	408.74

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error